Anti-IgLON5 disease presenting with myokymia and favourable response to FcRN-antagonist combined with oral glucocorticoids: case report - Top-Institutions - MDSpire

Anti-IgLON5 disease presenting with myokymia and favourable response to FcRN-antagonist combined with oral glucocorticoids: case report

  • By

  • Tianling Shang

  • Bo Ma

  • Shumei Wen

  • Zuohong Tang

  • Xiaoliang Mao

  • Keping Jiao

  • June 29, 2026

  • 0 min

Share

Top Institutions in Neurology

Brief introduction explaining scope and methodology.

  • #1

    Hospital Clínic de Barcelona / IDIBAPS
    Hospital Clínic de Barcelona / IDIBAPS

    Barcelona, Spain

    Key Differentiators

    • Neurology
    • Neuroimmunology

  • #2

    Mayo Clinic – Center for Multiple Sclerosis and Autoimmune Neurology
    Mayo Clinic – Center for Multiple Sclerosis and Autoimmune Neurology

    Rochester, Minnesota

    Key Differentiators

    • Neurology
    • Autoimmune Neurology

  • #3

    Peking University First Hospital
    Peking University First Hospital

    Beijing, China

    Key Differentiators

    • Neurology

Original Source(s)

Anti-IgLON5 disease presenting with myokymia and favourable response to FcRN-antagonist combined with oral glucocorticoids: case report

  • by Tianling Shang, Bo Ma, Shumei Wen, Zuohong Tang, Xiaoliang Mao, Keping Jiao

  • June 29, 2026

Related Content

From brain scans to classifiers: A systematic review of ML-based autism diagnostic frameworks

Metabolic Health Tied to Dementia

In two population-based cohorts, metabolically unhealthy status generally showed higher dementia risk estimates, while metabolically healthy obesity was not associated with increased risk in primary analyses.

Steroid-resistant bilateral facial nerve palsies, ophthalmoparesis, and multilevel thoracic radiculopathy as immune effector cell-associated late-onset neurotoxicity after cilta-cel CAR-T therapy: a case report and review of similar cases